Quintiles was named to the CSO40, which is for security professionals in a broad range of disciplines.
We usually don't post press releases on our site about awards, however, this one for Quintiles looks at cloud computing and security, so we thought it a bit different. Quintiles was named to the CSO40—CSO is a content site for security professions ls in a broad range of disciplines. Specifically they focus on information security, physical security, business continuity, identity and access management, loss prevention and more. The Award recognizes 40 organizations for security projects and initiatives that demonstration outstanding business value and thought leadership. Quintiles' Trusted Cloud Services Model was recognized.
The security issues for cloud computing are a debate in our industry. But Quintiles has addressed these concerns ensuring cloud service providers are subject to the same level of security assurance as internal systems.Quintiles' approach builds upon its global security framework and application security assessment program, extending security controls directly into cloud service providers’ environments.
Read the full release here.
Putting Collective Insights Into Action to Advance Cancer Care: Key Examples From ASCO 2025
June 27th 2025At ASCO 2025, clinical operations leaders gained critical insights into how AI tools, bispecific antibodies, and evolving treatment paradigms are reshaping trial design, endpoint selection, and patient stratification.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Funding Cuts Threaten Diversity in Clinical Research
June 27th 2025In this video interview, Kyle McAllister, co-founder, CEO, Trially, discusses how recent federal funding cuts are likely to undermine research focused on underrepresented populations, and why long-term investment in community-based studies is essential to closing persistent health equity gaps.